Estimating heterogeneity of treatment effect in psychiatric clinical trials

Currently, placebo-controlled clinical trials report mean change and effect sizes, which masks information about heterogeneity of treatment effects (HTE). Here, we present a novel method to estimate HTE and evaluate the null hypothesis (H(0)) that a drug has equal benefit for all participants (HTE = 0). We developed a measure termed ‘estimated heterogeneity of treatment effect’ or eHTE, which compares the distributions between study arms to test for heterogeneity in drug response – rather than…

via https://pubmed.ncbi.nlm.nih.gov/41129860/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20251105010906&v=2.18.0.post22+67771e2